Screener
Zevra Therapeutics, Inc. ZVRA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accounts and other receivables | 22,489 | 23,258 |
| Prepaid expenses and other current assets | 4,794 | 6,998 |
| Inventories, current | 2,449 | 1,740 |
| Total current assets | 251,302 | 223,007 |
| Investments, noncurrent | 38,609 | 47,879 |
| Inventories, noncurrent | — | 879 |
| Property and equipment, net | 641 | 489 |
| Operating lease right-of-use assets | 1,667 | 1,212 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s total current assets?
- Zevra Therapeutics, Inc. (ZVRA) reported total current assets of $251.3M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s total current assets changed year-over-year?
- Zevra Therapeutics, Inc.'s total current assets increased by 11.0% year-over-year, from $226.34M to $251.3M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total current assets has grown at a 92.7% compound annual growth rate (CAGR), from $8.38M to $223.01M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Zevra Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude